查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲核酸样品製备市场分析与预测：2022-2032
市场调查报告书
商品编码
1382599

欧洲核酸样品製备市场分析与预测：2022-2032

Europe Nucleic Acid Sample Preparation Market - Analysis and Forecast, 2022-2032
出版日期: | 出版商: BIS Research | 英文 107 Pages | 商品交期: 1-5个工作天内

价格

欧洲核酸样品製备市场规模预计将从 2022 年的 13.074 亿美元成长到 2032 年的 33.567 亿美元，预测期内年复合成长率为 9.89%。

核酸分子在各个医学领域的使用机会的增加预计将推动欧洲核酸样品製备市场的成长。此外，该地区的核酸样品製备市场正在扩大，这主要是由于对次世代定序（NGS）等下游应用以及与核酸萃取/分离技术相关的其他发展的需求不断增长所推动。

对快速诊断资讯和有针对性的患者治疗的需求不断增长也推动了市场的成长。为了满足这项需求，已经开发了多种分子程序，包括自动化核酸样品製备工作站。此外，样品製备在精准医疗中发挥重要作用，确保个体化治疗的可靠和有效应用。

本报告调查了欧洲核酸样品製备市场，并提供了市场概况，分析了市场成长的各种影响因素、法律制度、市场规模趋势和预测，以及各个细分市场、地区和主要国家的详细分析。,竞争形势、主要企业分析等

主要市场统计数据
预测期 2022-2032
2022年评估 13.074 亿美元
2032年预测 33.567 亿美元
年复合成长率 9.89%

市场区隔

细分 1：按国家/地区

  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 英国
  • 欧洲其他地区

目录

第1章市场

  • 产品定义
  • 市场范围
  • 调查方法
  • 市场概况
    • 市场定义
    • 市场规模/成长潜力
  • 潜在市场规模/成长潜力
    • 欧洲
  • 参加企业形势

第2章核酸样品製备市场：产业分析

  • 业界考察
    • 欧洲法律要求和框架
  • 专利分析
  • COVID-19对核酸样本製备市场的影响

第3章核酸样品製备市场：市场动态

  • 概述
  • 市场驱动因素
    • 核酸分子在各个治疗领域的应用不断增加
    • 核酸萃取分离技术进展
    • 自动化样品製备工作站的优点
    • 次世代定序(NGS) 等下游应用的需求不断增加
  • 市场抑制因素
    • 自动化工作站高成本
    • 严格的法规标准
  • 市场机会
    • 自动化样品製备工作站的技术进步
    • 用于生物样本库的核酸分子
    • 新兴国家的成长

第4章竞争形势

  • 概述
  • 企业策略
  • 经营策略
  • 市场占有率分析

第5章核酸样品製备市场：依地区

  • 概述
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第6章公司简介

  • Endress+Hauser Group Services AG (Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG
Product Code: BHP1512SS

“The Europe Nucleic Acid Sample Preparation Market Expected to Reach $3,356.7 Million by 2032.”

Introduction to Europe Nucleic Acid Sample Preparation Market

The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032. The increased use of nucleic acid molecules in a variety of medicinal contexts is expected to fuel the growth of the nucleic acid sample preparation market in Europe. Furthermore, the region's nucleic acid sample preparation market is expanding due in large part to the increased demand for downstream applications such as next-generation sequencing (NGS) and other associated developments in nucleic acid extraction/isolation techniques.

KEY MARKET STATISTICS
Forecast Period2022 - 2032
2022 Evaluation$1,307.4 Million
2032 Forecast$3,356.7 Million
CAGR9.89%

Market Introduction

The nucleic acid sample preparation market in Europe is currently advancing to meet the increasing demand for prompt diagnostic information and targeted patient treatment. Various molecular procedures, including automated nucleic acid sample preparation workstations, have been developed to address this need. Furthermore, sample preparation plays a crucial role in precision medicine, ensuring the secure and effective application of personalized therapies. The market provides a diverse range of universal products with varying maximum throughputs, innovations, time durations, and other attributes, prompting companies to explore inventive ways to differentiate themselves. Notably, manufacturers have recently introduced application-specific nucleic acid purification devices and liquid handlers to cater to specific needs in the European market.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Market Segmentation:

Segmentation 1: by Country

  • Germany
  • France
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

In 2021, Europe accounted for a share of 31.14% of the nucleic acid sample preparation market. The presence of some of the prominent companies in the market is a key factor driving the growth of the Europe region.

Recent Developments in the Europe Nucleic Acid Sample Preparation Market

  • In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.

How can this report add value to an organization?

Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current Europe nucleic acid sample preparation market.

Competitive Strategy: Key players in the Europe nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

  • Endress+Hauser Group Services AG
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG

Table of Contents

1 Market

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion Criteria
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
  • 1.3 Research Methodology
    • 1.3.1 Nucleic Acid Sample Preparation Market: Research Methodology
    • 1.3.2 Data Sources
      • 1.3.2.1 Primary Data Sources
      • 1.3.2.2 Secondary Data Sources
    • 1.3.3 Market Estimation Model
    • 1.3.4 Criteria for Company Profiling
  • 1.4 Market Overview
    • 1.4.1 Market Definition
    • 1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
  • 1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
    • 1.5.1 Europe
  • 1.6 Industry Participants Landscape

2 Nucleic Acid Sample Preparation Market, Industry Analysis

  • 2.1 Industry Insights
    • 2.1.1 Legal Requirements and Framework in Europe
  • 2.2 Patent Analysis
    • 2.2.1 Patent Filing Trend
    • 2.2.2 Patent Analysis (by Year)
    • 2.2.3 Patent Analysis (by Country)
    • 2.2.4 Patent Analysis (by Region)
  • 2.3 Impact of COVID-19 on the Nucleic Acid Sample Preparation Market

3 Nucleic Acid Sample Preparation Market: Market Dynamics

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
    • 3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
    • 3.2.3 Advantages of Automated Sample Preparation Workstations
    • 3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Automated Workstations
    • 3.3.2 Rigid Regulatory Standards
  • 3.4 Market Opportunities
    • 3.4.1 Technological Advancements in Automated Sample Preparation Workstations
    • 3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
    • 3.4.3 Growth in Emerging Nations

4 Competitive Landscape

  • 4.1 Overview
  • 4.2 Corporate Strategies
    • 4.2.1 Mergers and Acquisitions
    • 4.2.2 Synergistic Activities
    • 4.2.3 Business Expansions
  • 4.3 Business Strategies
    • 4.3.1 Product Launches
  • 4.4 Market Share Analysis

5 Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032

  • 5.1 Overview
  • 5.2 Europe
    • 5.2.1 Germany
    • 5.2.2 France
    • 5.2.3 U.K.
    • 5.2.4 Italy
    • 5.2.5 Spain
    • 5.2.6 Rest-of-Europe

6 Company Profiles

  • 6.1 Overview
  • 6.2 Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 6.2.1 Company Overview
    • 6.2.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
    • 6.2.3 Key Customers of the Company
    • 6.2.4 Key Competitors of the Company
    • 6.2.5 Business Strategies
    • 6.2.6 Financials
    • 6.2.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
    • 6.2.8 Key Insights about the Financial Health of the Company
    • 6.2.9 Analyst Perspective
  • 6.3 Eppendorf SE
    • 6.3.1 Company Overview
    • 6.3.2 Role of Eppendorf SE in the Nucleic Acid Sample Preparation Market
    • 6.3.3 Key Competitors of the Company
    • 6.3.4 Financials
    • 6.3.5 Key Insights about the Financial Health of the Company
    • 6.3.6 Analyst Perspective
  • 6.4 F. Hoffmann-La Roche Ltd
    • 6.4.1 Company Overview
    • 6.4.2 Role of F. Hoffmann-La Roche Ltd in the Nucleic Acid Sample Preparation Market
    • 6.4.3 Key Competitors of the Company
    • 6.4.4 Business Strategies
    • 6.4.5 Financials
    • 6.4.6 Key Insights about the Financial Health of the Company
    • 6.4.7 Analyst Perspective
  • 6.5 Merck KGaA
    • 6.5.1 Company Overview
    • 6.5.2 Role of Merck KGaA in the Nucleic Acid Sample Preparation Market
    • 6.5.3 Key Competitors of the Company
    • 6.5.4 Financials
    • 6.5.5 Key Insights about the Financial Health of the Company
    • 6.5.6 Analyst Perspective
  • 6.6 QIAGEN
    • 6.6.1 Company Overview
    • 6.6.2 Role of QIAGEN in the Nucleic Acid Sample Preparation Market
    • 6.6.3 Key Customers of the Company
    • 6.6.4 Key Competitors of the Company
    • 6.6.5 Business Strategies
    • 6.6.6 Financials
    • 6.6.7 Key Insights about the Financial Health of the Company
    • 6.6.8 Analyst Perspective
  • 6.7 Tecan Trading AG
    • 6.7.1 Company Overview
    • 6.7.2 Role of Tecan Trading AG in the Nucleic Acid Sample Preparation Market
    • 6.7.3 Key Customers of the Company
    • 6.7.4 Key Competitors of the Company
    • 6.7.5 Financials
    • 6.7.6 Key Insights about the Financial Health of the Company
    • 6.7.7 Analyst Perspective

List of Figures

  • Figure 1: Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
  • Figure 2: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 3: Share of Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
  • Figure 4: Share of Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
  • Figure 5: Share of Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
  • Figure 6: Share of Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
  • Figure 7: Share of Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
  • Figure 8: Share of Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
  • Figure 9: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 10: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 11: Nucleic Acid Sample Preparation Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 16: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 17: Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
  • Figure 18: Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
  • Figure 19: Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
  • Figure 20: Virus Testing Workflow
  • Figure 21: NGS Applications in Laboratories during COVID-19
  • Figure 22: Nucleic Acid Sample Preparation Market - Market Dynamics
  • Figure 23: Techniques for Nucleic Acid Extraction/Isolation
  • Figure 24: Benefits of Automated Nucleic Acid Sample Preparation
  • Figure 25: Share of Key Developments, January 2019-November 2022
  • Figure 26: Share of Synergistic Activities (by Company), January 2019-November 2022
  • Figure 27: Number of Business Expansion Activities (by Company), January 2019-November 2022
  • Figure 28: Number of Product Launches (by Company), January 2019-November 2022
  • Figure 29: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
  • Figure 30: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 31: Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
  • Figure 32: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 33: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
  • Figure 34: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 35: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 36: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 37: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 38: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 39: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 40: Total Number of Companies Profiled
  • Figure 41: Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
  • Figure 42: Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
  • Figure 43: Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
  • Figure 44: Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
  • Figure 45: Eppendorf SE: Product Portfolio
  • Figure 46: Eppendorf SE: Overall Financials, $Million, 2019-2021
  • Figure 47: Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
  • Figure 48: Eppendorf SE: Revenue (by Region), $Million, 2019-2021
  • Figure 49: Eppendorf SE: R&D Expenditure, $Million, 2019-2021
  • Figure 50: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 51: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
  • Figure 52: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
  • Figure 53: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
  • Figure 54: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
  • Figure 55: Merck KGaA: Product Portfolio
  • Figure 56: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 57: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
  • Figure 58: Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 59: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 60: QIAGEN: Product Portfolio
  • Figure 61: QIAGEN: Overall Financials, 2019-2021
  • Figure 62: QIAGEN: Revenue (by Segment), 2019-2021
  • Figure 63: QIAGEN: Revenue (by Region), 2019-2021
  • Figure 64: QIAGEN: R&D Expenditure, 2019-2021
  • Figure 65: Tecan Trading AG: Product Portfolio
  • Figure 66: Tecan Trading AG: Overall Financials, 2019-2021
  • Figure 67: Tecan Trading AG: Revenue (by Segment), 2019-2021
  • Figure 68: Tecan Trading AG: Revenue (by Region), 2019-2021
  • Figure 69: Tecan Trading AG: R&D Expenditure, 2019-2021

List of Tables

  • Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Nucleic Acid Sample Preparation Market
  • Table 2: Industry Participants' Landscape in the Nucleic Acid Sample Preparation Market
  • Table 3: Cost of Automated Workstations